Showing 2800 results
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +12% USD) with core operating income1 up +21% (cc, +20% USD)Sales growth driven by continued strong performance from Kisqali (+…
-
Story /
-
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 280
- › Next page